| Code | Description | Claims | Beneficiaries | Total Paid |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
4,798 |
4,789 |
$5.04M |
| Q9991 |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
1,810 |
1,735 |
$2.95M |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
1,776 |
1,743 |
$2.85M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
29 |
25 |
$184K |
| J0897 |
Injection, denosumab, 1 mg |
37 |
37 |
$49K |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
14 |
12 |
$45K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
12 |
12 |
$12K |